Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Santino Butler"'
Autor:
Yizheng Chen, Michael F. Gensheimer, Hilary P. Bagshaw, Santino Butler, Lequan Yu, Yuyin Zhou, Liyue Shen, Nataliya Kovalchuk, Murat Surucu, Daniel T. Chang, Lei Xing, Bin Han
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Publikováno v:
Cureus.
Autor:
Brandon A. Mahal, Kent W. Mouw, Vinayak Muralidhar, Anju Nohria, Amanda Whitbeck, Santino Butler, Paul L. Nguyen, Javid Moslehi, Edward Christopher Dee, Janet Wangoe, Rishi Makkar
Publikováno v:
Cancer. 127:2213-2221
Background For men with radiation-managed prostate cancer, there is conflicting evidence regarding the association between androgen deprivation therapy (ADT) and cardiovascular mortality (CVM), particularly among those who have with preexisting comor
Autor:
Felix Y. Feng, Neil E. Martin, Vinayak Muralidhar, Martin T. King, Nayan Lamba, Quoc-Dien Trinh, Jonathan E. Leeman, Paul L. Nguyen, Brandon A. Mahal, Peter F. Orio, Santino Butler, Brent S. Rose, Kent W. Mouw
Publikováno v:
Urology. 145:197-203
To inform treatment decisions for patients with high-risk prostate cancer (PCa), we determined rates of adverse pathologic factors and overall survival (OS) among subgroups of high-risk men.Using the National Cancer Database, 89,450 patients with cli
Autor:
Paul L. Nguyen, Fallon E. Chipidza, Edward Christopher Dee, David D. Yang, Brandon A. Mahal, Melaku A Arega, Santino Butler, Vinayak Muralidhar, Michelle D. Nezolosky, Sybil T. Sha
Publikováno v:
The Prostate. 80:1128-1133
Objective To estimate contemporary population-based patterns of the relative burden of prostate cancer-specific mortality (PCSM) attributable to each N0M0 prostate cancer risk-group, that may guide prioritization in research, trial design, and clinic
Autor:
Santino Butler, Amanda Whitbeck, Nayan Lamba, Rishi Makkar, Vinayak Muralidhar, Brandon A. Mahal, Sybil T. Sha, Paul L. Nguyen, Edward Christopher Dee, Kent W. Mouw, Janet Wangoe
Publikováno v:
Cancer. 126:2132-2138
Background A subgroup of men with favorable high-risk prostate cancer (T1c with either a Gleason score of 4 + 4 = 8 and a prostate-specific antigen [PSA] level 20 ng/mL) has been associated with improved outcomes in comparison with other standard hig
Autor:
Paul L. Nguyen, Daniel E. Spratt, Oliver Sartor, Santino Butler, Brandon A. Mahal, Elai Davicioni, Qiqi Wang, Kent W. Mouw, Vinayak Muralidhar, Jingbin Zhang, Felix Y. Feng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:621-627
Recent data and National Comprehensive Cancer Network (NCCN) guidelines suggest that high-risk prostate cancer (cT3-4, Gleason score ≥8, or prostate-specific antigen [PSA]20 ng/mL) is a heterogenous group in terms of long-term patient outcomes. We
Autor:
Paul L. Nguyen, Edward Christopher Dee, Ryan D. Nipp, Vinayak Muralidhar, Zizi Yu, Nina N. Sanford, Brandon A. Mahal, Santino Butler
Publikováno v:
Supportive Care in Cancer.
A growing proportion of cancer survivors experience financial toxicity. However, the psychological burden of cancer costs and associated mental health outcomes require further investigation. We assessed prevalence and predictors of self-reported fina
Autor:
Martin T. King, Vinayak Muralidhar, Nina N. Sanford, Brandon A. Mahal, Melaku A Arega, Robert T. Dess, Sybil T. Sha, Patricia Mae G. Santos, Santino Butler, Paul L. Nguyen, Edward Christopher Dee, Daniel E. Spratt, Amar U. Kishan
Publikováno v:
International journal of radiation oncology, biology, physics. 109(5)
Treatment noncompletion may occur with radiation therapy (RT), especially with protracted treatment courses such as RT for prostate cancer, and may affect the efficacy of RT. For men with localized prostate cancer managed with primary RT, we evaluate
Autor:
Vinayak Muralidhar, Edward Christopher Dee, Martin T. King, Paul Nguyen, Santino Butler, Kent W. Mouw, Sybil T. Sha, Anthony V. D'Amico, Brandon A. Mahal, David Y. Yang, Zizi Yu
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:For men with Gleason score 9-10 prostate cancer, studies have demonstrated conflicting results on the outcomes from combination radiation therapy (ComboRT) with external ...